98 related articles for article (PubMed ID: 26148596)
1. Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition.
Richard SM; Martinez Marignac VL
J Cancer Res Ther; 2015; 11(2):336-40. PubMed ID: 26148596
[TBL] [Abstract][Full Text] [Related]
2. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
3. Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells.
Liu C; Liu Q; Yan A; Chang H; Ding Y; Tao J; Qiao C
Cancer Med; 2020 Jun; 9(11):3875-3884. PubMed ID: 32248666
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
5. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
Attoub S; Arafat K; Khalaf T; Sulaiman S; Iratni R
Nutrients; 2018 May; 10(5):. PubMed ID: 29724012
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.
Flis S; Spłwiński J
Anticancer Res; 2009 Jan; 29(1):435-41. PubMed ID: 19331183
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
Folkvord S; Flatmark K; Seierstad T; Røe K; Rasmussen H; Ree AH
Radiother Oncol; 2008 Mar; 86(3):428-34. PubMed ID: 18006097
[TBL] [Abstract][Full Text] [Related]
8. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Hua H; Chen W; Shen L; Sheng Q; Teng L
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
[TBL] [Abstract][Full Text] [Related]
9. The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines.
Xu JM; Azzariti A; Colucci G; Paradiso A
Cancer Chemother Pharmacol; 2003 Dec; 52(6):442-8. PubMed ID: 13680161
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines.
Rakitina TV; Vasilevskaya IA; O'Dwyer PJ
Biochem Pharmacol; 2007 Jun; 73(11):1715-26. PubMed ID: 17343830
[TBL] [Abstract][Full Text] [Related]
11. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
[TBL] [Abstract][Full Text] [Related]
12. Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin.
Lin YM; Chen CI; Hsiang YP; Hsu YC; Cheng KC; Chien PH; Pan HL; Lu CC; Chen YJ
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899208
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy.
Van Schaeybroeck S; Karaiskou-McCaul A; Kelly D; Longley D; Galligan L; Van Cutsem E; Johnston P
Clin Cancer Res; 2005 Oct; 11(20):7480-9. PubMed ID: 16243822
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitro.
Tanaka R; Ariyama H; Qin B; Shibata Y; Takii Y; Kusaba H; Baba E; Mitsugi K; Harada M; Nakano S
Oncol Rep; 2005 Sep; 14(3):683-8. PubMed ID: 16077975
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
Kornmann M; Fakler H; Butzer U; Beger HG; Link KH
Anticancer Res; 2000; 20(5A):3259-64. PubMed ID: 11062751
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of p110β expression increases chemosensitivity of colon cancer cell lines to oxaliplatin.
Liu W; Wang G; Cao X; Luo X; Li Z; Deng Y; Li X; Wang S; Liu M; Hu J; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):280-286. PubMed ID: 22528234
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.
Ametller E; García-Recio S; Pastor-Arroyo EM; Callejo G; Carbó N; Gascón P; Almendro V
Cancer Biol Ther; 2011 Jan; 11(1):4-13. PubMed ID: 20980803
[TBL] [Abstract][Full Text] [Related]
18. Low dose chemotherapeutic drugs without overt cytotoxic effects decrease the secretion of VEGF by cultured human tumor cells: a tentative relationship between drug type and tumor cell type response.
Aktas SH; Akbulut H; Akgun N; Icli F
Cancer Biomark; 2012-2013; 12(3):135-40. PubMed ID: 23481572
[TBL] [Abstract][Full Text] [Related]
19. The HDAC6 inhibitor ACY‑1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.
Lee DH; Won HR; Ryu HW; Han JM; Kwon SH
Int J Oncol; 2018 Aug; 53(2):844-854. PubMed ID: 29749542
[TBL] [Abstract][Full Text] [Related]
20. Silencing of CD59 enhanced the sensitivity of HT29 cells to 5-Fluorouracil and Oxaliplatin.
Yin H; Li C; Wang S; Guo Q; Ren X; Jiang G
J Infect Chemother; 2015 Jan; 21(1):8-15. PubMed ID: 25444672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
